Fortis Healthcare announced that would be inaugurating the Fortis Institute of Genomic Medicine, a high-tech setup aimed at rejuvenating patient care with the facility's goal to settle...
The Foreign Trade Policy (FTP) 2023's Appendix 2K has been updated by the Directorate General of Foreign Trade (DGFT), requiring pharmaceutical imports and exports to pay a registration fee through the Import Monitoring System (IMS). The objective o
.png)
The United States Food and Drug Administration (US FDA) has designated Venus Remedies Limited, a Panchkula-based pharmaceutical company that specializes in critical care injectables, as a Qualified Infectious Disease Product (QIDP) for the....
Amidst the ongoing difficulties in global commerce brought on by US-China tariffs, India's medical equipment industry is seeing a startling increase in imports. Citing the possibility of serious harm to the domestic economy, the Association of Indian
The campaign that spreads ResolverRAT through phishing emails uses a remote access trojan and targets the healthcare and pharmaceutical sectors. These emails are written in...
The Indian pharmaceutical industry has approached the Drug Controller General of India (DCGI), filing a plea for relaxation of the...
.png)
The United States Food and Drug Administration (USFDA) has given Zydus Lifesciences final approval to produce medications called Jaythari (Deflazacort).
In a strategic approach to regulating the rapidly growing diagnostic sector, the state health department has made it mandated registration of all diagnostic labs under the Clinical Establishment Act (CEA) 2010. Despite repeated notifications at both
The Indian Pharma Market (IPM) created a conducive growth environment in 2025 for March at 9.3% YoY, which shows a remarkable recovery from the months gone by. Key growth drivers included Cipla...
Cipla made significant progress after obtaining USFDA permission for marketing its generic cancer drug. The USFDA granted Cipla authorization to introduce their paclitaxel protein-bound particles for injectable suspension (albumin-bound) under the br
, CDSCO.jpg)
